Armistice Capital »

Delcath Sys shares owned by Armistice Capital

Quarter-by-quarter ownership of Delcath Sys (DCTH) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Delcath Sys

Tip: Access up to 7 years of quarterly data

All positions including Delcath Sys held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Delcath Sys by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $664k 164k 4.05

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Supernus Pharmaceuticals (SUPN)
Argenx Se Sponsored Adr (ARGX)
Deciphera Pharmaceuticals (DCPH)
Agios Pharmaceuticals (AGIO)
Immunovant (IMVT)
Sanofi Sponsored Adr (SNY)
Aurinia Pharmaceuticals (AUPH)
Dentsply Sirona (XRAY)
Travere Therapeutics (TVTX)

View all positions for Armistice Capital

Top funds holding Delcath Sys

AIGH Capital Management
Vivo Capital
BVF
Rosalind Advisors
Vanguard Group
CIBC World Markets
Geode Capital Management
ADAR1 Capital Management
Susquehanna International
Hunting Hill Global Capital
Morgan Stanley
BlackRock
Citadel Advisors
Marshall Wace
Northern Trust

View all funds holding Delcath Sys